Wellington Biomedical Innovation Master Investors (Cayman) I L.P. - 10%+ Owner at Acrivon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ACRV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Wellington Biomedical Innovation Master Investors (Cayman) I L.P. since 11/5/2023

Holdings reported by Wellington Biomedical Innovation Master Investors (Cayman) I L.P. for Acrivon Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 888K $3.86M $4.35 Nov 17, 2022 Direct
Series B Preferred Stock 0 Nov 17, 2022 Direct Common Stock

Transactions reported by Wellington Biomedical Innovation Master Investors (Cayman) I L.P. for Acrivon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.